Glucose monitoring in type 2 diabetes.
A major goal in the treatment of type 2 diabetes is to maintain blood glucose values in the normal or near normal range. A system of monitoring glycemic control, which includes self-monitoring of blood glucose (SMBG) by the patient, and frequent glycated protein assays, is an important tool for achieving this goal. Optimal use of SMBG by the patient is best accomplished through comprehensive glucose monitoring education, which includes appropriate monitor selection and use and strategies to use monitoring results to improve glycemic control.
Cunningham
M A
MA
Loyola University Medical Center, Maywood, Illinois 60153, USA.
D015982:Bias; D001786:Blood Glucose / Q000032:analysis; D015190:Blood Glucose Self-Monitoring / Q000379:methods* / Q000592:standards; D002138:Calibration; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000378:metabolism* / Q000628:therapy*; D018450:Disease Progression; D019270:Fructosamine / Q000097:blood; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D008487:Medical History Taking; D009730:Nursing Assessment; D010347:Patient Care Planning; D010353:Patient Education as Topic / Q000379:methods; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D011237:Predictive Value of Tests; D011934:Reagent Strips; D015203:Reproducibility of Results; D012648:Self Care / Q000379:methods
D001786:Blood Glucose; D019270:Fructosamine; D006442:Glycated Hemoglobin; D011934:Reagent Strips